




Searching News Database: telavancin
HSMN NewsFeed - 2 Dec 2019
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line
Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line
HSMN NewsFeed - 9 May 2016
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
Theravance Biopharma Announces FDA Approval of Expanded Label for VIBATIV(R) (telavancin)
HSMN NewsFeed - 27 Nov 2009
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
HSMN NewsFeed - 5 Nov 2009
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United States
HSMN NewsFeed - 27 Dec 2007
Theravance Receives Notice of Possible Telavancin Review by FDA Advisory Committee
Theravance Receives Notice of Possible Telavancin Review by FDA Advisory Committee
HSMN NewsFeed - 5 Dec 2007
Theravance Announces Positive Topline Results In Phase 3 Telavancin Hospital-Acquired Pneumonia Program
Theravance Announces Positive Topline Results In Phase 3 Telavancin Hospital-Acquired Pneumonia Program
HSMN NewsFeed - 31 Jul 2007
Theravance Announces Appointment of Leonard M. Blum as Chief Commercial Officer
Theravance Announces Appointment of Leonard M. Blum as Chief Commercial Officer
Additional items found! 7

Members Archive contains
7 additional stories matching:
telavancin
(Password required)
telavancin
(Password required)